Pasco Medical Ltd. is aiming to develop, build and sell a new comprehensive instrument for the early diagnosis of debilitating eye disease. The instrument will be portable, provide front to back eye examination capabilities and be powered with AI to help identify the earliest onset of disease and provide live recommendations to clinicians performing tests. According to WHO in 2019, more than 2.2 billion people have a vision impairment and at least half of them could have been prevented had earlier diagnoses been made.This new model of medical device will promote several benefits such as reduced strain on overstretched national health services, greater patient access and earlier intervention leading to greater chance of healthy recovery. It will change the quality of life for millions of people.
Company’s Keywords:
<2
<
<
<2021